Loading
Enzymatica AB (publ) Stock: price and insider trades · Sweden
2 insiders bought €20k of shares over the last 90 days, the latest filed 02 Sept 2026.
Enzymatica AB (publ): what insiders have been doing
Every trade that managers of Enzymatica AB (publ) disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. The last twelve months, up to 18 October 2026, brought 5 filings signed by 3 insiders.
On the market, 2 insiders bought (4 purchases totalling €20k) while 1 insider sold (1 sale totalling €11k). On balance, insiders were net buyers of €8,726. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The largest single trade was a sale of €11k by Anna Söderlund, published on 1 April 2026, equal to 0.025% of the market capitalisation. Among those who bought: 1 finance chief and 1 chief executive.
Across the 890 companies tracked on its exchange, the median is 7 filings; at 5 filings, this issuer sits below that mark. Over the whole record (from 2025), the tally stands at 10 purchases and 1 sale.
The clock since the last published purchase (2 September 2026) now reads 45 days. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades.
In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Insider Decl.
11
Thresholds
n/a
Buy Volume
€130,700
10 ops. · all time
Sell Volume
€10,959
1 ops. · all time
Who traded when
BuySaleAnna Söderlund2 buys1 sale
Sana Alajmovic3 buys
Helene Willberg2 buys
Bengt Baron1 buy
Holger Lembrér1 buy
Mats Andersson1 buy
Since the insiders bought
- -5.9%Entry SEK 2.02 · Close 16 Oct 2026 SEK 1.90
- +0.0%Entry SEK 1.86 · Close at T+30 SEK 1.86
- -19.1%Entry SEK 2.35 · Close 16 Oct 2026 SEK 1.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fundamental score
Ranked 21,595 of 24,158 companies
22.9
score / 100
Value16
Quality30
FCF yld-8.9%
Earn yld-11%
EV/EBITDA·
ROE-38%
Gross mgn61%
Net mgn-96%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 1.90
Analyst consensus
Income statement
RevenueSEK 53.9M
Gross profitSEK 33.1M61% margin
EBITDA-SEK 46.4M-86% margin
Net income-SEK 51.9M-88.3% margin
Valuation
P/Book4.7x
Beta-0.38
Balance sheet & cash
Market capSEK 461.2M
Total debtSEK 1M
Free Cash Flow-SEK 41.2M
Debt / Equity14%
Profitability & ownership
ROE-37.9%
ROA-20.0%
% insiders62.7%
% institutions9.9%
Last declaration on 2 September 2026
Declarations11 total
10,869 shares@ SEK 1.840.0050% mcap18.3% of flowAktieISIN SE0003943620FI:csv-0fa5021ae5ceddc89447
Canonical exit: 30 Nov 2026 (T+90)
15,555 shares@ SEK 1.850.0072% mcap26.3% of flowAktieISIN SE0003943620FI:csv-d698c141b119ec21c9f7
Canonical exit: 30 Nov 2026 (T+90)
33,384 shares@ SEK 1.80910.015% mcap55.4% of flowAktieISIN SE0003943620FI:csv-c3077e88973ed0a2b77e
Canonical exit: 26 Nov 2026 (T+90)
50,000 shares@ SEK 2.200.028% mcap100.0% of flowAktieISIN SE0003943620FI:csv-3d2139c01430eeb17881
Canonical exit: 15 Oct 2026 (T+90)
40,000 shares@ SEK 3.000.025% mcap32.1% of flowAktieISIN SE0003943620FI:A003X482-1
230,000 shares@ SEK 2.36430.11% mcap100.0% of flowAktieISIN SE0003943620FI:A003S437-1
Canonical exit: 17 Dec 2025 (T+90)
48,000 shares@ SEK 3.080.031% mcap36.0% of flowAktieISIN SE0003943620FI:A003M475-1
Canonical exit: 10 Jun 2025 (T+90)
50,000 shares@ SEK 2.800.029% mcap37.5% of flowAktieISIN SE0003943620FI:A003M472-1
Canonical exit: 10 Jun 2025 (T+90)
40,000 shares@ SEK 2.860.023% mcap30.4% of flowAktieISIN SE0003943620FI:A003M250-1
Canonical exit: 4 Jun 2025 (T+90)
3,500 shares@ SEK 2.900.0021% mcap100.0% of flowAktieISIN SE0003943620FI:A003M244-1
Canonical exit: 4 Jun 2025 (T+90)
100,000 shares@ SEK 2.68920.054% mcap64.0% of flowAktieISIN SE0003943620FI:A003M153-1
Canonical exit: 1 Jun 2025 (T+90)
11 of 11 declarations
About Enzymatica AB (publ)
Enzymatica AB (publ) is a Swedish company focused on the development of health and pharmaceutical products. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
